| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/28/2005 | US20050165027 Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide |
| 07/28/2005 | US20050165019 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 07/28/2005 | US20050165017 Such as (3S)-2-[3-[(phenylacetyl)amino]-1-oxopropyl]-N-[cyano(3-phenoxyphenyl)methyl]hexahydro-3-pyridazinecarboxamide; for treatment of osteoporosis, hypercalcaemia, osteoporosis, gingival disease, arthritis, Paget's disease, and bone cancer |
| 07/28/2005 | US20050165016 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/28/2005 | US20050164995 Method of locking 1alpha-OH of vitamin D compounds in axial orientation |
| 07/28/2005 | US20050164993 Methods of treating allergic reactions |
| 07/28/2005 | US20050164989 Novel $g(a)-amino-n-(diaminophosphinyl) lactam derivative |
| 07/28/2005 | US20050164988 Bisphosphate, bis-quaternary ammonium or bis-amine salt compounds that bind a Toll-like receptor; use desensitizing allergies, treating autoimmune diseases and inflammatory diseases, ischemia |
| 07/28/2005 | US20050164964 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases |
| 07/28/2005 | US20050164936 Antiinflammatory and antitumor agents; human T-cell leukemia/lymphoma virus and lymphadenopathy associated virus treatment; angiogenic- or hematopoiesis-related diseases; medical diagnosis |
| 07/28/2005 | US20050164927 Aqueous sustained-release formulations of proteins |
| 07/28/2005 | US20050164923 Use of soluble fgl2 as an immunosuppresant |
| 07/28/2005 | US20050164917 Methods and means for producing proteins with predetermined post-translational modifications |
| 07/28/2005 | US20050164906 Inhibitors of the Mitogen Activated Protein Kinases (MAPKs) pathway activated by Ras/Raf complex using GILZ (glucocorticoid-Induced Leucine Zipper) protein related compounds as inhibitors of Raf/Ras-mediated signal transduction; anticarcinogenic agents |
| 07/28/2005 | US20050164342 Cloned glutamic acid decarboxylase |
| 07/28/2005 | US20050164307 Methods of screening agonistic antibody |
| 07/28/2005 | US20050164185 Interferon receptor variant for treatment and prevention of cell proliferative, autoimmune and viral diseases; prolonged activation of interferon beta |
| 07/28/2005 | US20050163863 use of arsenic for treating autoimmune diseases, in particular autoimmune lymphoproliferative syndrome |
| 07/28/2005 | US20050163797 Also comprises neuroactive compounds, hormones, compounds having growth hormone acitivity, and polypeptide; vaccines; selected HCV antigens together with the polyamino acid adjuvants, especially polyarginine, and optionally the immunogenic compounds |
| 07/28/2005 | US20050163793 Methods for recovering peptides from stress protein-peptide complexes |
| 07/28/2005 | US20050163792 Stress protein joined to another component, such as a fusion protein in which a stress protein is fused to an antigen |
| 07/28/2005 | US20050163790 Method of treatment and agents useful for same |
| 07/28/2005 | US20050163780 Administering antagonist of a GP39, selected from an antibody which specifically bind GP39, soluble CD40 and soluble CD40 fusion proteins |
| 07/28/2005 | US20050163778 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/28/2005 | US20050163770 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 07/28/2005 | US20050163767 useful as a diagnostic marker or a drug target for bronchial asthma, chronic obstructive pulmonary disease; isolated antibody which specifically binds to a specific protein belonging to the chitinase family |
| 07/28/2005 | US20050163762 activating auto-antigen specific T cells such as AChR-specific T cells in an auto-immune disease patient such as myasthenia gravis; virus for transferring genes to antigen presenting cells so that they express, process, and present an antigen which will stimulate antigen-specific T cells |
| 07/28/2005 | US20050163724 Contains steroidal anti-inflammatory drug, carrier (saccharides, sugar alcohols, amino acids), and water |
| 07/28/2005 | CA2553953A1 Therapeutic use of quinonoid derivatives of cannabinoids |
| 07/28/2005 | CA2552965A1 Carboxamide derivative and use thereof |
| 07/28/2005 | CA2551879A1 Use of interleukin-21 for the treatment of autoimune diseases and allograft rejection |
| 07/27/2005 | EP1557670A1 REGULATION OF INTERACTION BETWEEN RAPL AND Rap1 |
| 07/27/2005 | EP1557462A2 Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 07/27/2005 | EP1557428A1 Antibodies against a human stromal derived factor (SDF) and pharmaceutical composition containing them |
| 07/27/2005 | EP1557407A1 Novel alpha-ketoamide derivative and use thereof |
| 07/27/2005 | EP1557177A1 Antigen for transcutaneous immunisation |
| 07/27/2005 | EP1557173A1 Soluble CTLA4 mutant molecules and uses thereof |
| 07/27/2005 | EP1557172A1 Method and composition for regulating the activity of regulatory t cells |
| 07/27/2005 | EP1556488A2 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 07/27/2005 | EP1556401A2 22 human secreted proteins |
| 07/27/2005 | EP1556369A1 Pyridazinone-derivatives as pde4 inhibitors |
| 07/27/2005 | EP1556357A1 Compounds, compositions, and methods |
| 07/27/2005 | EP1556356A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 07/27/2005 | EP1556347A2 Gamma lactams as prostaglandin agonists and use thereof |
| 07/27/2005 | EP1556330A2 Phenyl compounds |
| 07/27/2005 | EP1556081A2 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 07/27/2005 | EP1556075A2 Compositions for the treatment of autoimmune disorders |
| 07/27/2005 | EP1556074A2 Casein derived peptides and uses thereof in therapy |
| 07/27/2005 | EP1556066A2 Compositions and methods of use for a fibroblast growth factor |
| 07/27/2005 | EP1556055A2 Use of cyclic nucleotide phosphodiesterase inhibitors having a benzodiazepine structure in therapy |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 07/27/2005 | EP1556008A1 Use of bases for the manufacture of a medicament in the treatment of different forms of inflammatory dermatosis |
| 07/27/2005 | EP1351961B1 Substituted indolines as 5-ht receptor ligands |
| 07/27/2005 | EP1339711B1 Aminothiazoles and their use as adenosine receptor antagonists |
| 07/27/2005 | EP1313736B1 Condensed pyrazindione derivatives as inhibitors of pde5 |
| 07/27/2005 | EP1289559B1 Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/27/2005 | EP1272185B1 Use of quinazoline derivatives as angiogenesis inhibitors |
| 07/27/2005 | EP1263757B1 Benzthiazoles as tnf and pde-iv inhibitors |
| 07/27/2005 | EP1237877B1 Carboxamide-substituted benzimidazol derivatives, methods for the production thereof and their use as medicaments |
| 07/27/2005 | EP1053018B1 DELIVERY OF IMMUNOGENIC MOLECULES VIA HBsAg PARTICLES |
| 07/27/2005 | CN1646693A Enveloped microorganism |
| 07/27/2005 | CN1646684A Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 07/27/2005 | CN1646564A 修饰的因子Ⅷ Modification factor Ⅷ |
| 07/27/2005 | CN1646558A Histone deacetylase inhibitors and process for producing the same |
| 07/27/2005 | CN1646554A Sialic carbohydrates |
| 07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
| 07/27/2005 | CN1646535A Pyrrolopyrimidine derivative |
| 07/27/2005 | CN1646526A Tropane derivatives as CCR5 modulators |
| 07/27/2005 | CN1646520A 1, 3, 5-triazine derivatives as ligands for human adenosine-A3 receptors |
| 07/27/2005 | CN1646508A 5-substituted 1, 1-dioxo-1, 2, 5-thiazolidine-3-one derivatives as PTP ase 1B inhibitors |
| 07/27/2005 | CN1646505A Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
| 07/27/2005 | CN1646499A Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 07/27/2005 | CN1646173A Microparticles comprising carbohydrate beads covalently linked with allergen |
| 07/27/2005 | CN1646161A Reagents and treatment methods for autoimmune diseases |
| 07/27/2005 | CN1646159A Immunoadjuvant |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646152A Mannose binding lectin and uses thereof |
| 07/27/2005 | CN1646151A Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
| 07/27/2005 | CN1646148A Drugs including anticancer agents and immunopotentiators and health foods and drinks |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646138A Novel therapeutical use of agonist ligands specific to G2A receptor |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646122A A medicament for preventing and/or treating chronic rejection |
| 07/27/2005 | CN1646119A Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2005 | CN1646110A Tolterodine salts |
| 07/27/2005 | CN1646100A Dispersed solid-containing complex carbohydrate |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1645143A Method of detecting immune response |
| 07/27/2005 | CN1644214A YG and YGG used as maintenance and improvement of immunoreaction |
| 07/27/2005 | CN1644203A Oral preparation of red common stone crop polysaccharide and its making method |
| 07/27/2005 | CN1644199A Use of ampeloptin in preparation of antivirus medicines |
| 07/27/2005 | CN1212398C Novel IFN receptor 1 binding proteins, DNA encoding them, and method of modulating cellular response to interferons |
| 07/27/2005 | CN1212335C ICE hibiting peptides |
| 07/27/2005 | CN1212153C Immunologic adjuvant origniated from plants, and its preparing method and use |
| 07/27/2005 | CN1212151C Capsule of cordyceps |
| 07/26/2005 | US6921826 Thioether substituted imidazoquinolines |
| 07/26/2005 | US6921825 Pyrazolo-triazolo- pyrimidine, triazolo-triazolo-pyrimidine and imidazolo-triazolo-pyrimidine derivatives useful for the treatment of hypertension, inflammation, mast cell degranulation, cardiac hypoxia, and ischemia |
| 07/26/2005 | US6921763 Protein kinase inhibitors |